Mdm2 and MdmX (also known as Mdm4) are key regulators of the p53 tumor suppressor. Previous work by our lab and by many other groups has determined that these MDM proteins complex with p53 and inhibit p53 functions, with Mdm2 inducing p53 ubiquitination and proteosomal degradation, and MdmX inhibiting p53 transactivation of p53 target gene expression. As such, Mdm2 and MdmX act as critical negative regulators of p53 tumor suppressing functions, and amplification of either the MDM2 or MDMX gene is observed in a significant percentage of human tumors. In this proposal, we summarize the progress we have made in our previous studies on p53 regulation by MDM and other cellular proteins. We also describe our very recent studies examining in vitro the effects of Mdm2 phosphorylation in the regulation of p53 stability and activity, as well as our discovery of p53-independent roles for MdmX in suppressing proliferation and tumorigenesis in p53-null cells and mice. Based upon our preliminary data, we now propose to utilize genetically modified mice bearing amino acid substitutions in Mdm2 in order to examine in vivo the effects of Mdm2 phosphorylation on Mdm2-MdmX-p53 signaling and on p53 functions in development and tumor suppression. We also propose to further characterize p53-independent functions of MdmX in the regulation of cell transformation and chromosomal stability. This research should greatly increase our understanding of the roles of these MDM proteins in regulating cell growth and death, and the functional relationship between these homologues in DNA damage signaling and in p53-dependent and p53-independent suppression of tumorigenesis.
Mdm2 and MdmX (also known as Mdm4) are key negative regulators of the p53 tumor suppressor. Although much has been learned from transfection studies and from biochemical assays about the interconnecting roles of Mdm2 and MdmX in regulating p53, analysis of genetically modified mice has proven critical in substantiating the numerous and often conflicting models proposed for Mdm2 and MdmX regulation of p53 functions, and in developing new theories regarding the function of MDM proteins in cancer. We propose to analyze new mouse models to explore the effects of Mdm2 phosphorylation on Mdm2 and MdmX levels and functions. We also propose to continue our MdmX studies in cells and in mice to better understand and define the p53- independent roles for MdmX in transformation and chromosomal stability, and to identify MdmX-interacting proteins that mediate these effects. The results of these experiments will have clinical relevance, as an understanding of the regulatory mechanisms that control p53 activity in normal cell growth and in tumorigenesis is a critical prerequisite to developing new therapies to treat cancer in the significant percentage of patients who present with tumors bearing alterations in the Mdm2-MdmX-p53 signaling pathway.
|Carr, Michael I; Jones, Stephen N (2016) Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis. Transl Cancer Res 5:707-724|
|Matijasevic, Z; Krzywicka-Racka, A; Sluder, G et al. (2016) The Zn-finger domain of MdmX suppresses cancer progression by promoting genome stability in p53-mutant cells. Oncogenesis 5:e262|
|Lyle, Stephen; Hoover, Kathleen; Colpan, Cansu et al. (2014) Dicer cooperates with p53 to suppress DNA damage and skin carcinogenesis in mice. PLoS One 9:e100920|
|Shin, JongDae; Wallingford, Mary C; Gallant, Judith et al. (2014) RLIM is dispensable for X-chromosome inactivation in the mouse embryonic epiblast. Nature 511:86-9|
|Gannon, Hugh S; Woda, Bruce A; Jones, Stephen N (2012) ATM phosphorylation of Mdm2 Ser394 regulates the amplitude and duration of the DNA damage response in mice. Cancer Cell 21:668-79|
|Regeling, Anouk; Armata, Heather L; Gallant, Judy et al. (2011) Mice defective in p53 nuclear localization signal 1 exhibit exencephaly. Transgenic Res 20:899-912|
|Gannon, Hugh S; Donehower, Lawrence A; Lyle, Stephen et al. (2011) Mdm2-p53 signaling regulates epidermal stem cell senescence and premature aging phenotypes in mouse skin. Dev Biol 353:1-9|
|Mudhasani, Rajini; Puri, Vishwajeet; Hoover, Kathleen et al. (2011) Dicer is required for the formation of white but not brown adipose tissue. J Cell Physiol 226:1399-406|
|Gaur, Tripti; Hussain, Sadiq; Mudhasani, Rajini et al. (2010) Dicer inactivation in osteoprogenitor cells compromises fetal survival and bone formation, while excision in differentiated osteoblasts increases bone mass in the adult mouse. Dev Biol 340:10-21|
|Coles, Andrew H; Gannon, Hugh; Cerny, Anna et al. (2010) Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity. Proc Natl Acad Sci U S A 107:11423-8|
Showing the most recent 10 out of 12 publications